Correlation Between Atreca and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Atreca and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atreca and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atreca Inc and Travere Therapeutics, you can compare the effects of market volatilities on Atreca and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atreca with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atreca and Travere Therapeutics.
Diversification Opportunities for Atreca and Travere Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Atreca and Travere is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Atreca Inc and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Atreca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atreca Inc are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Atreca i.e., Atreca and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Atreca and Travere Therapeutics
If you would invest 1,937 in Travere Therapeutics on December 4, 2024 and sell it today you would earn a total of 43.00 from holding Travere Therapeutics or generate 2.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Atreca Inc vs. Travere Therapeutics
Performance |
Timeline |
Atreca Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Travere Therapeutics |
Atreca and Travere Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Atreca and Travere Therapeutics
The main advantage of trading using opposite Atreca and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atreca position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |